Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

32.90

+1.96 (6.33%)

At close: Jun 15, 2026, 4:00 PM EDT

32.88

-0.02 (-0.06%)

After-hours: Jun 15, 2026, 7:59 PM EDT

Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	157.83	112.28	69.53	66.39	59.97	142.75
Short-Term Investments	222.01	230.86	188.39	270.5	306.17	342.51
Cash & Short-Term Investments	379.84	343.14	257.92	336.89	366.13	485.26
Cash Growth	75.26%	33.04%	-23.44%	-7.99%	-24.55%	154.97%
Accounts Receivable	-	-	-	-	2	2
Other Current Assets	12.49	10.62	8.43	9.65	7.14	5.08
Total Current Assets	392.33	353.76	266.34	346.54	375.27	492.34
Net Property, Plant & Equipment	41.03	42.49	47.58	53.42	57.77	6.09
Other Long-Term Assets	2.43	2.44	2.57	2.61	3.43	1.73
Total Assets	435.79	398.69	316.49	402.57	436.47	500.16
Accounts Payable	2.43	1.18	1.6	2.79	4.45	3.23
Accrued Expenses	9.07	17.76	16.5	15.4	17.5	9.89
Current Portion of Leases	2.83	2.74	2.45	2.08	1.77	1.5
Unearned Revenue	-	-	17.62	25.67	31.79	26.02
Other Current Liabilities	-	-	-	-	0.04	0.05
Total Current Liabilities	14.33	21.68	38.17	45.94	55.55	40.69
Long-Term Leases	29.96	30.83	34.04	36.84	39.36	-
Other Long-Term Liabilities	-	-	44.77	66.68	92.09	114.72
Total Long-Term Liabilities	29.96	30.83	78.81	103.52	131.45	114.72
Total Liabilities	44.29	52.51	116.98	149.46	186.99	155.41
Common Stock	0.14	0.14	0.11	0	0.09	0.09
Additional Paid-in Capital	1,040	948.97	700.63	624.08	522.61	506.76
Accumulated Other Comprehensive Income	-0.12	0.22	0.34	0.19	-3.71	-0.77
Retained Earnings	-648.67	-603.15	-501.56	-371.26	-269.51	-161.34
Total Common Shareholders' Equity	391.51	346.18	199.52	253.11	249.48	344.75
Shareholders' Equity	391.51	346.18	199.52	253.01	249.48	344.75
Total Liabilities & Equity	435.79	398.69	316.49	402.57	436.47	500.16
Total Debt	32.79	33.57	36.49	38.92	41.13	1.5
Net Cash (Debt)	347.05	309.57	221.42	297.97	325	483.75
Net Cash Growth	12.11%	39.81%	-25.69%	-8.32%	-32.82%	165.16%
Net Cash Per Share	2.76	2.67	2.03	3.15	3.70	7.79
Book Value	391.51	346.18	199.52	253.11	249.48	344.75
Book Value Per Share	3.11	2.98	1.83	2.68	2.84	5.55
Tangible Book Value	391.51	346.18	199.52	253.11	249.48	344.75
Tangible Book Value Per Share	3.11	2.98	1.83	2.68	2.84	5.55

SEC Filings: 10-K · 10-Q